Key Insights
- Shared Mathematical Structures: Emerging evidence indicates that AI models and human brains may develop similar representational patterns for concepts like "apple," driven by shared data and optimization processes, though this convergence is partial and context-dependent.
- Path to Cyberpunk Realities: Advances in BCIs suggest we're approaching enhanced human capabilities, with medical applications like vision restoration already in trials, but widespread augmentation for healthy individuals remains speculative and likely 10–20 years away due to technical, regulatory, and ethical hurdles.
- Max Hodak's Contributions: As a BCI pioneer, Hodak's work at Science Corp focuses on practical innovations like the Prima implant, while envisioning bolder ideas such as biohybrid brain extensions, emphasizing both restoration and potential enhancement.
- Ethical and Social Implications: While BCIs promise revolutionary benefits, they raise concerns about access disparities, privacy risks, and identity shifts, potentially exacerbating social inequalities if costs remain high.
- After Neuralink, Max Hodak is building something even wilder
- Can The Brain Merge With Artificial Intelligence? — With Max Hodak
- Prima Visual Prosthesis - Science Corporation
- Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy
- Eye prosthesis is the first to restore sight lost to macular degeneration
- "Platonic Representation Hypothesis": Is AI converging on a common model of reality?
- Ethical considerations for the use of brain–computer interfaces
Convergence Between AI and the Brain
Studies show that as AI systems scale, their internal representations of objects and ideas increasingly align with neural patterns in the human brain. For instance, multimodal AI models group concepts semantically and visually in ways that mirror brain activity, suggesting a common "language" shaped by real-world data. However, experts note this isn't universal—differences arise from silicon vs. biological substrates—and full equivalence is debated.
Research on the Platonic Representation Hypothesis posits that as models scale, they converge on a shared, abstract model of reality, potentially validating ancient philosophical ideas about universal forms. However, this isn't a perfect match; AI lacks the brain's embodied experience and evolutionary biases, leading to occasional divergences, such as over-reliance on statistical correlations rather than causal understanding.
Breakthroughs in BCI Technology
Max Hodak, co-founder of Neuralink and CEO of Science Corp (founded 2021), describes how examining AI models reveals mathematical objects akin to those in brain scans, particularly in how both systems optimize for efficiency in processing information.
Science Corp's Prima implant is a wireless subretinal photovoltaic device designed to combat advanced retinal diseases like geographic atrophy from age-related macular degeneration (AMD). Unlike traditional approaches that target damaged photoreceptors, Prima bypasses them entirely, using near-infrared light from augmented reality glasses to stimulate bipolar cells deeper in the retina. A pivotal study published in the *New England Journal of Medicine* in October 2025 involved 38 participants, demonstrating significant vision restoration, with many able to read letters and short texts—success rates hovered around 80% for regaining reading capabilities. The implant, smaller than a grain of rice, integrates with camera-equipped glasses and a pocket processor, with no batteries in the eye itself.
Hodak's "third hemisphere" idea proposes externally attaching hardware or biohybrid tissue to the brain, effectively adding a new computational layer. It builds on solving the "binding problem" in consciousness—how disparate neural features unify into a single perceptual experience. Hodak predicts patient-ready versions by 2035. Science Corp is exploring optogenetic gene therapies and neuron-seeded grids that grow into the cortex.
Timeline to Enhanced Realities
Current BCIs focus on medical restoration, with companies like Neuralink and Science Corp leading trials. The Prima implant could launch commercially in Europe by summer 2026, with U.S. approval following. A "cyberpunk" era of routine augmentation could emerge by the 2030s if safety and ethics are addressed, but widespread adoption might take 10–20 years.
Major BCI Initiatives Compared
| Company/Project | Focus | Key Achievement | Timeline/Status | Ethical Concerns | |---------------|-------|-----------------|-----------------|------------------| | Neuralink (Elon Musk) | General BCI for paralysis, enhancement | First human implants for cursor control | Ongoing trials; expansions planned for 2026 | Privacy, autonomy, animal testing controversies | | Science Corp (Max Hodak) | Vision restoration, biohybrids | Prima implant restores reading in 80% of AMD patients | EU launch summer 2026; US pending | High costs ($200k), access equity | | Synchron | Vascular BCI for motor impairment | Stent-based implant for texting/thought control | FDA-approved trials; commercial push by 2027 | Infection risks, data security | | Blackrock Neurotech | Utah Array implants | Long-term neural recording for research/clinical use | Decades of data; integrations with AI | Invasive surgery, long-term biocompatibility |
Potential Costs and Ethical Dimensions
Enhancements could rewrite human evolution by enabling new sensory dimensions, but at ethical prices:
| Category | Description | Potential Impacts | Mitigation Strategies | |----------|-------------|-------------------|-----------------------| | Equity & Access | High costs and resource scarcity limit to wealthy | Widens socioeconomic gaps, "enhanced" vs. "natural" divide | Subsidies, public funding, international regulations | | Privacy & Security | Direct brain data access | Hacking, surveillance, mental manipulation | Encryption standards, consent frameworks, IRB oversight | | Identity & Autonomy | Neural alterations change self-perception | Redefines consciousness, binding problem solutions needed | Philosophical guidelines, user-controlled reversibility | | Societal | Economic strain from augmentation demand | Healthcare crises, job displacements via enhanced cognition | Policy reforms, ethical AI integration in BCIs |
BCIs challenge personal identity: altering neural pathways could redefine "who am I," raising questions of authenticity and agency. Economic realities exacerbate inequities: Prima's projected $200,000 cost limits access to the affluent, potentially creating a "neural divide." Hodak suggests 50 patients monthly could sustain operations, but broader adoption requires navigating these multifaceted challenges.
Conclusion
This convergence and BCI progress herald a transformative era, rewriting life's boundaries while demanding careful stewardship to balance innovation with humanity's core values.
For more on Science Corp's work, visit https://science.xyz.